Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia

Biological Psychiatry

Volumn 53, Issue 12, 2003, Pages 1075-1085

  Hof, Patrick R ^a   Haroutunian, Vahram ^a,b   Friedrich Jr , Victor L ^a   Byne, William ^a,b   Buitron, Cristian ^a   Perl, Daniel P ^a   Davis, Kenneth L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Myelin; Oligodendrocyte; Prefrontal cortex; Schizophrenia; Stereology; White matter

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; BIOLOGICAL MARKER;

ANISOTROPY; ANTIBODY LABELING; ARTICLE; BRAIN REGION; CELL COUNT; CELL LOSS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIA; PATHOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; STEREOMETRY; SUPERIOR FRONTAL GYRUS; WHITE MATTER;

EID: 0037839787     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00237-3     Document Type: Article

References (67)

1. Akbarian S., Bunney W.E. Jr, Potkin S.G., Wigal S.B., Hagman J.O., Sandman C.A., Jones E.G. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry. 50:1993;169-177.
2. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr, Jones E.G. Gene expression for glutamic decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:1995;258-266.
3. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney W.E. Jr, Jones E.G. Maldistribution of interstitial neurons in prefrontal white mater of the brains of schizophrenic patients. Arch Gen Psychiatry. 53:1996;425-436.
4. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci. 16:1996;19-30.
5. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Tripartite synapses Glia, the unacknowledged partner . Trends Neurosci. 22:1999;208-215.
6. Arnold S.E., Trojanowski J.Q. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. 92:1996;217-231.
7. Arnold S.E., Trojanowski J.Q., Gur R.E., Blackwell P., Han L.Y., Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry. 55:1998;225-232.
8. Bergles D.E., Roberts J.D.B., Somogyi P., Jahr C.E. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature. 405:2000;187-191.
9. Bouras C., Kövari E., Riederer B.M., Hof P.R., Giannakopoulos P. Morphological alterations in the anterior cingulate cortex in drug-naive patients with schizophrenia and bipolar disorder. Acta Neuropathol. 102:2001;373-379.
10. Buchsbaum M.S., Tang C.Y., Peled S., Gubjartsson H., Lu D., Hazlett E.A., et al. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. NeuroReport. 9:1998;425-430.
11. Bussière T., Friend P.D., Sadeghi N., Wicinski B., Lin G.I., Bouras C., et al. Stereologic determination of the total cortical volume occupied by amyloid deposition and correlation with cognitive status in normal brain aging and Alzheimer's disease. Neuroscience. 112:2002;75-91.
12. Bussière T, Gold G, Kövari E, Giannakopoulos P, Bouras C, Perl DP, et al (2003): Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience.
13. Byne W., Buchsbaum M.S., Hazlett E.A., Kemether E., Elhakem S.L., Purohit D.P., et al. Postmortem assessment of thalamic nuclei in schizophrenia. Am J Psychiatry. 159:2002;59-65.
14. Davis KL, Stewart DG, Friedman J, Buchsbaum MS, Harvey P, Hof PR, et al (in press): White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arch Gen Psychiatry.
15. Dracheva S., Marras S.A.E., Elhakem S.L., Kramer F.R., Davis K.L., Haroutunian V. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry. 158:2001;1400-1410.
16. Duyckaerts C., Godefroy G. Voronoi tesselation to study the numerical density and the spatial distribution of neurones. J Chem Neuroanat. 20:2000;83-92.
17. Foong J., Maier M., Barker G.J., Brocklehurst S., Miller D.H., Ron M.A. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatry. 68:2000;70-74.
18. Foong J., Symms M.R., Barker G.J., Maier M., Woermann F.G., Miller D.H., Ron M.A. Neuropathological abnormalities in schizophrenia Evidence from magnetization transfer imaging . Brain. 124:2001;882-892.
19. Friedman J.I., Harvey P.D., Coleman T., Moriarty P.J., Bowie C., Parrella M., et al. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia A comparison with Alzheimer's disease and normal aging . Am J Psychiatry. 158:2001;1441-1448.
20. Gao X.M., Sakai K., Roberts R.C., Conley R.R., Dean B., Tamminga C.A. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus Effects of schizophrenia . Am J Psychiatry. 157:2000;1141-1149.
21. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 65:1998;446-453.
22. Glantz L.A., Austin M.C., Lewis D.A. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry. 48:2000;389-397.
23. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry. 54:1997;943-952.
24. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A. 98:2001;4746-4751.
25. Harding A.J., Wong A., Svoboda M., Kril J.J., Halliday G.M. Chronic alcohol consumption does not cause hippocampal neuron loss in humans. Hippocampus. 7:1997;78-87.
26. Haydon P.G. Glia Listening and talking to the synapse . Nature Rev Neurosci. 2:2001;185-193.
27. Hof P.R., Haroutunian V., Copland C., Davis K.L., Buxbaum J.D. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res. 27:2002;1193-1200.
28. Hommer D., Momenan R., Kaiser E., Rawlings R. Evidence for gender-related effect of alcoholism on brain volumes. Am J Psychiatry. 158:2001;198-204.
29. Hyde T.M., Ziegler J.C., Weinberger D.R. Psychiatric disturbances in metachromatic leukodystrophy Insights into the neurobiology of psychosis . Arch Neurol. 49:1992;401-406.
30. Ibrahim H.M., Hogg A.J. Jr, Healy D.J., Haroutunian V., Davis K.L., Meador-Woodruff J.H. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry. 157:2000;1811-1823.
31. Kalus P., Müller T.J., Zuschratter W., Senitz D. The dendritic architectre of prefrontal pyramidal neurons in schizophrenic patients. NeuroReport. 11:2000;3621-3625.
32. Kril J.J., Halliday G.M. Brain shrinkage in alcoholics A decade on and what have we learned . Prog Neurobiol. 58:1999;381-387.
33. Kril J.J., Halliday G.M., Svoboda M.D., Cartwright H. The cerebral cortex is damaged in alcoholics. Neuroscience. 79:1997;983-998.
34. Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 24:2001;39-47.
35. Lewis D.A. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Rev. 31:2000;270-276.
36. Lewis D.A., Gonzalez-Burgos G. Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia. Brain Res Bull. 52:2000;309-317.
37. Lewis D.A., Lieberman J.A. Catching up on schizophrenia Natural history and neurobiology . Neuron. 28:2000;325-334.
38. Lim K.O., Hedehus M., Moseley M., de Crespigny A., Sullivan E.V., Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry. 56:1999;367-374.
39. Matute C., Sanchez-Gomez M., Martinez-Millan L., Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci U S A. 94:1997;8830-8835.
40. Mayfield R.D., Lewohl J.M., Dodd P.R., Herlihy A., Liu J., Harris R.A. Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J Neurochem. 81:2002;802-813.
41. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Med. 4:1998;291-297.
42. Mirnics K., Middleton F.A., Lewis D.A., Levitt P. Analysis of complex brain disorders with gene expression microrarrays Schizophrenia as a disease of the synapse . Trends Neurosci. 24:2001;479-486.
43. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2000;53-67.
44. Möller J. Lectures on Random Voronoi Tesselations. 1994;Springer, New York.
45. Nimchinsky E.A., Young W.G., Yeung G., Shah R.A., Gordon J.W., Bloom F.E., et al. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. J Comp Neurol. 416:2000;112-125.
46. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 52:1995;998-1007.
47. Pakkenberg B. Leucotomized schizophrenics lose neurons in the mediodorsal thalamic nucleus. Neuropathol Appl Neurobiol. 19:1993;373-380.
48. Perl D.P., Good P.F., Bussière T., Morrison J.H., Erwin J.M., Hof P.R. Practical approaches to stereology in the setting of aging- and disease-related brain banks. J Chem Neuroanat. 20:2000;7-19.
49. Peters A., Palay S.L., Webster H.deF. The Fine Structure of the Nervous System The Neurons and Supporting Cells . 1991;Oxford University Press, New York.
50. Petrides M., Pandya D.N. Dorsolateral prefrontal cortex Comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns . Eur J Neurosci. 11:1999;1011-1036.
51. Pierri J.N., Chaudry A.S., Woo T.U.W., Lewis D.A. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry. 156:1999;1709-1719.
52. Pierri J.N., Volk C.L.E., Auh S., Sampson A., Lewis D.A. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry. 58:2001;466-473.
53. Popken G.J., Bunney W.E. Jr, Potkin S.G., Jones E.G. Subnucleus-specific loss of neurons in edial thalamus of schizophrenics. Proc Natl Acad Sci U S A. 97:2000;9276-9280.
54. Purohit D.P., Perl D.P., Haroutunian V., Powchik P., Davidson M., Davis K.L. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia. Arch Gen Psychiatry. 55:1998;205-211.
55. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex I. Remapping of areas 9 and 46 using quantitative criteria . Cereb Cortex. 5:1995;307-322.
56. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 49:2002;741-752.
57. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex. A postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 55:1998;215-224.
58. Rosoklija G., Tooyaman G., Ellis S.P., Keilp J., Mann J.J., Latov N., et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders. Preliminary findings. Arch Gen Psychiatry. 57:2000;349-356.
59. Schmitz C., Hof P.R. Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J Chem Neuroanat. 20:2000;93-114.
60. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. Arch Gen Psychiatry. 52:1995;805-818.
61. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients Application of a three-dimensional stereologic counting method . J Comp Neurol. 392:1998;402-412.
62. Théberge J., Bartha R., Drost D.J., Menon R.S., Malla A., Takhar J., et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry. 159:2002;1944-1946.
63. Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V., Rachmanova V. Electron microsopy of oligodendroglia in severe mental illness. Brain Res Bull. 55:2001;597-610.
64. Vaughan D.W. The structure of neuroglial cells. Jones E.G., Peters A. Functional Properties of Cortical Cells, Cerebral Cortex, Vol 2. 1984;285-329 Plenum, New York.
65. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia Decreased expression in a subset of neurons . Am J Psychiatry. 158:2001;256-365.
66. West M.J., Slomianka L., Gundersen H.J.G. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec. 231:1991;482-497.
67. Young K.A., Manaye K.F., Liang C.L., Hicks P.B., German D.C. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry. 47:2000;944-953.